Pfizer's COVID-19 Vax: A Good First Step, Say Experts

(MedPage Today) -- Reaction was generally--but not universally--positive to Pfizer's and BioNTech's announcement that their mRNA COVID-19 vaccine candidate was more than 90% effective in interim phase III trial results.
Matthew Spinelli...